Company / Current Liabilities per Share
Sana Biotechnology, Inc. Current Liabilities per Share History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.20
FY2024
5-year range
$0.20 / $2.42
FY2020-FY2024
Trend
-40.6%
vs FY2023
Sector context
#192 of 210
Health Care
What the data says
Among 210 Health Care companies, Sana Biotechnology, Inc. is in the top 9% for current liabilities per share. Current Liabilities per Share has declined for 4 consecutive years, from $2.42 in FY2020 to $0.20 in FY2024.
Based on SEC 10-K filings.
0.20 in FY2024 with a 3-year CAGR of -30.9%.
Improved from $0.59 to $0.20 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -30.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 9% in Health CareTop 9% of 210This company $0.20 Sector average $23.79
▼
-99.2% below sector average
Key checks
Key Insights
- Sana Biotechnology, Inc.'s current liabilities per share has declined for 4 consecutive years.
- In FY2024, current liabilities per share decreased 40.6% year-over-year.
- Ranks #192 out of 210 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.11 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.20 | -40.6% |
| FY2023 | $0.33 | -44.0% |
| FY2022 | $0.59 | -0.7% |
| FY2021 | $0.60 | -75.3% |
| FY2020 | $2.42 | - |
| FY2019 | - | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026